Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares UltraPro Short S&P500 ETF
SPXU
5
Short Russell 2000 Proshares
RWM
US Stock MarketDetailed Quotes
CBUS Cibus Inc
- 2.070
- 0.0000.00%
Trading May 7 11:41 ET
67.56MMarket Cap-0.19P/E (TTM)
2.146High2.030Low6.36KVolume2.110Open2.070Pre Close13.26KTurnover0.03%Turnover RatioLossP/E (Static)32.64MShares19.56252wk High0.73P/B52.23MFloat Cap1.40052wk Low--Dividend TTM25.23MShs Float1594.500Historical High--Div YieldTTM5.62%Amplitude1.400Historical Low2.085Avg Price1Lot Size
About Cibus Inc Company
Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as Canola, Rice, Soybean, Corn and Wheat. The company was founded by Rory Riggs, Peter Beetham and Greg Gocal in 2001 and is headquartered in San Diego, CA.
Company Profile
SymbolCBUS
Company NameCibus Inc
Listing DateJul 20, 2017
Founded2001
CEODr. Peter Beetham, PhD
MarketNASDAQ
Employees159
Fiscal Year Ends12-31
Address6455 Nancy Ridge Drive
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-450-0008
Websitehttp://www.cibus.com
Company Executives
- Name
- Position
- Salary
- Dr. Peter Beetham, PhD
- Director, President, Chief Operating Officer and Interim Chief Executive Officer
- 500.01K
- Jason Stokes, Esq.
- Chief Legal Officer, General Counsel and Corporate Secretary
- --
- Cornelis Broos
- Interim Chief Financial Officer and Principal Accounting Officer
- 551.49K
- Dr. Greg Gocal, PhD
- Chief Scientific Officer and Executive Vice President
- --
- Noel Sauer
- Senior Vice President, Research
- --
- Rory B. Riggs
- Chairman of the Board of Company and Cibus Global
- 500.01K
- Mark Terrence Finn
- Lead Independent Director
- 252.44K
- Jean-Pierre Jules Lehmann
- Independent Director
- 202.44K
- August J. Moretti
- Independent Director
- 54.69K
- Dr. Keith Allen Walker, PhD
- Independent Director
- 202.44K
- Dr. Gerhard Prante, PhD
- Independent Director
- 239.47K
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
